Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Zygomycosis.

Corina E Gonzalez1, Michael G Rinaldi, Alan M Sugar

  • 1Division of Pediatric Hematology-Oncology, Department of Pediatrics, Georgetown University Hospital, 3800 Reservoir Road NW, Washington, DC 20007, USA. gonzalec@georgetown.edu

Infectious Disease Clinics of North America
|January 7, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Resolution of PML after Treatment with Virus-Specific T Cells and HCT.

The New England journal of medicine·2026
Same author

Cryptosporidiosis in inborn errors of immunity: a single center cohort and review of the literature.

The Journal of infectious diseases·2026
Same author

Clinical features, genetics, treatment, and long-term outcomes of STAT3 hyper-IgE syndrome: Single-center cohort analysis.

The Journal of allergy and clinical immunology·2026
Same author

Extended clinical phenotypes and long-term outcomes of phosphoglucomutase-3 deficiency.

Journal of human immunity·2026
Same author

Further Personalizing Medicine in Immune Disorders: Genomic Findings and Hematopoietic Cell Transplantation Survival.

Transplantation·2025
Same author

Restoration of the human skin microbiome following immune recovery after hematopoietic stem cell transplantation.

Cell host & microbe·2025
Same journal

Prevention and Control of Clostridioides difficile Infection for the Infectious Diseases Clinician.

Infectious disease clinics of North America·2026
Same journal

Infection Control Strategies to Prevent Emergence and Transmission of Resistant Gram-Negative Bacteria.

Infectious disease clinics of North America·2026
Same journal

Preventing the Spread of Tuberculosis in Health Care Settings.

Infectious disease clinics of North America·2026
Same journal

Threats to Success: Principles of Infection Prevention and Control in Health Care Settings, Part 2: Device and Pathogen Management.

Infectious disease clinics of North America·2026
Same journal

Ventilator-Associated Events: Surveillance and Prevention.

Infectious disease clinics of North America·2026
Same journal

Nosocomial Fungal Infections: Epidemiology, Control Strategies, and Prevention of Candida and Other Yeasts.

Infectious disease clinics of North America·2026
See all related articles

Zygomycosis is a rare but deadly fungal infection. Effective treatment combines early diagnosis, antifungal drugs, and surgical removal of infected tissue.

Area of Science:

  • Mycology
  • Infectious Diseases

Background:

  • Zygomycosis is an uncommon, often fatal opportunistic infection caused by Zygomycetes fungi.
  • Rarity limits novel therapeutic strategy development and testing.

Purpose of the Study:

  • To outline effective therapeutic strategies for zygomycosis.

Main Methods:

  • Review of existing treatment approaches for zygomycosis.
  • Emphasis on combined therapeutic modalities.

Main Results:

  • Successful treatment relies on early diagnosis and prompt medical intervention.
  • Surgical debridement of non-viable tissue is crucial.
  • High-dose lipid formulations of amphotericin B show potential.
  • Reversing predisposing conditions and hyperbaric oxygen are also noted strategies.

Related Experiment Videos

Conclusions:

  • A multifaceted treatment approach is essential for managing zygomycosis.
  • Key components include early detection, aggressive medical and surgical management, and supportive therapies.